메뉴 건너뛰기




Volumn 172, Issue 5, 1995, Pages 1238-1245

Weak Binding of VX-478 to Human Plasma Proteins and Implications for Anti-Human Immunodeficiency Virus Therapy

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; PROTEINASE; PROTEINASE INHIBITOR;

EID: 0028877042     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/172.5.1238     Document Type: Article
Times cited : (73)

References (31)
  • 1
    • 0027179491 scopus 로고
    • Present status and future prospects for HIV therapies
    • Johnston MI, Hoth DF. Present status and future prospects for HIV therapies. Science 1993;260:1286 -1291
    • (1993) Science , vol.260
    • Johnston, M.I.1    Hoth, D.F.2
  • 2
    • 0025221948 scopus 로고
    • Human immunodeficiency virus protease: A target for AIDS therapy
    • Debouck C, Metcalf BW. Human immunodeficiency virus protease: a target for AIDS therapy. Drug Dev Res 1990;21:1-17
    • (1990) Drug Dev Res , vol.21 , pp. 1-17
    • Debouck, C.1    Metcalf, B.W.2
  • 4
    • 0025952925 scopus 로고
    • HIV protease: A novel chemotherapeutic target for AIDS
    • Huff JR. HIV protease: a novel chemotherapeutic target for AIDS. J Med Chem 1991;34:2305-2314
    • (1991) J Med Chem , vol.34 , pp. 2305-2314
    • Huff, J.R.1
  • 5
    • 0027218692 scopus 로고
    • Structure-based inhibitors of HIV-1 protease
    • Wlodawer A, Erickson JW. Structure-based inhibitors of HIV-1 protease. Annu Rev Biochem 1993;62:543-585
    • (1993) Annu Rev Biochem , vol.62 , pp. 543-585
    • Wlodawer, A.1    Erickson, J.W.2
  • 6
    • 0028248489 scopus 로고
    • HIV protease as an inhibitor target for the treatment of AIDS
    • Darke PL, Huff JR. HIV protease as an inhibitor target for the treatment of AIDS. Adv Pharmacol 1994;25:399-454
    • (1994) Adv Pharmacol , vol.25 , pp. 399-454
    • Darke, P.L.1    Huff, J.R.2
  • 7
    • 0027969994 scopus 로고
    • The design of a potent orally bioavailable HIV protease inhibitor
    • 735, 524
    • Dorsey BD, Levin RB, McDaniel SL, et al. 735, 524: the design of a potent orally bioavailable HIV protease inhibitor. J Med Chem 1994; 37:344-351
    • (1994) J Med Chem , vol.37 , pp. 344-351
    • Dorsey, B.D.1    Levin, R.B.2    Mc Daniel, S.L.3
  • 8
    • 0028110476 scopus 로고
    • Use of proteinase inhibitors in clinical practice
    • Pollard R. Use of proteinase inhibitors in clinical practice. Pharmacotherapy 1994; 14:21S-9S
    • (1994) Pharmacotherapy , vol.14
    • Pollard, R.1
  • 9
    • 0028968902 scopus 로고
    • ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans
    • Kempf DJ, Marsh KV, Denissen JF, et al. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Nall Acad Sci USA 1995;92:2484-2488
    • (1995) Proc Nall Acad Sci USA , vol.92 , pp. 2484-2488
    • Kempf, D.J.1    Marsh, K.V.2    Denissen, J.F.3
  • 10
    • 84959793850 scopus 로고    scopus 로고
    • Evaluation of the antiviral activity of orally administered ABT-538, an inhibitor of HIV-1 protease [abstract 185]
    • (Washington, DC).Washington, DC: American Society for Microbiology
    • Markowitz M, Jalil L, Hurley A, et al. Evaluation of the antiviral activity of orally administered ABT-538, an inhibitor of HIV-1 protease [abstract 185]. In: Program and abstracts of the 2nd National Conference on Human Retroviruses and Related Infections (Washington, DC). Washington, DC: American Society for Microbiology, 1995
    • Program and Abstracts of the 2Nd National Conference on Human Retroviruses and Related Infections , pp. 1995
    • Markowitz, M.1    Jalil, L.2    Hurley, A.3
  • 12
    • 84959833936 scopus 로고    scopus 로고
    • A randomized, double blind study of the oral HIV protease inhibitor, L-735, 524 vs. Zidovudine (ZDV) in p24 antigenemic, HIV-1 infected patients with <500 CD4 cells/mm3 [abstract 183]
    • Washington, DC: American Society for Microbiology
    • Mellors J, Steigbigcl R, Gulick R, et al. A randomized, double blind study of the oral HIV protease inhibitor, L-735, 524 vs. zidovudine (ZDV) in p24 antigenemic, HIV-1 infected patients with <500 CD4 cells/mm3 [abstract 183]. In: Program and abstracts of the 2nd National Conference on Human Retroviruses and Related Infections (Washington, DC). Washington, DC: American Society for Microbiology, 1995
    • Program and Abstracts of the 2Nd National Conference on Human Retroviruses and Related Infections (Washington, DC) , pp. 1995
    • Mellors, J.1    Steigbigcl, R.2    Gulick, R.3
  • 13
    • 0028811974 scopus 로고
    • Viral dynamics in human immunodeficiency virus type 1 infection
    • Wei X, Ghosh SK, Taylor ME, el al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122
    • (1995) Nature , vol.373 , pp. 117-122
    • Wei, X.1    Ghosh, S.K.2    Taylor, M.E.3
  • 14
    • 0028943992 scopus 로고
    • In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
    • Condra JH, Schleif WA, Blahy OM, el al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 1995;374:569-571
    • (1995) Nature , vol.374 , pp. 569-571
    • Condra, J.H.1    Schleif, W.A.2    Blahy, O.M.3
  • 18
    • 0027401867 scopus 로고
    • Pharmacokinetic study of a tripeptide HIV-1 protease inhibitor, KNi-174, in rats after intravenous and intraduodenal administrations
    • Kiriyama A, Mimoto T, Kiso Y, Takada K. Pharmacokinetic study of a tripeptide HIV-1 protease inhibitor, KNi-174, in rats after intravenous and intraduodenal administrations. Biopharm Drug Dispos 1993; 14:199-207
    • (1993) Biopharm Drug Dispos , vol.14 , pp. 199-207
    • Kiriyama, A.1    Mimoto, T.2    Kiso, Y.3    Takada, K.4
  • 19
    • 0028231995 scopus 로고
    • Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentration proteins
    • Kageyama SS, Anderson BD, Hoesterey BL, et al. Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentration proteins. Antimicrob Agents Chemother 1994;38:1107-1111
    • (1994) Antimicrob Agents Chemother , vol.38 , pp. 1107-1111
    • Kageyama, S.S.1    Erson, B.D.2    Hoesterey, B.L.3
  • 20
    • 0025955611 scopus 로고
    • Ct al. Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease
    • Kcmpf DJ, Marsh KC, Paul DA, ct al. Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother 1991; 35:2209-2214
    • (1991) Antimicrob Agents Chemother , vol.35 , pp. 2209-2214
    • Kcmpf, D.J.1    Marsh, K.C.2    Paul, D.A.3
  • 21
    • 0028951411 scopus 로고
    • Reduction of the in vitro activity of A77003, an inhibitor of human immunodeficiency virus protease, by human serum «¡-acid glycoprotein
    • Bilello JA, Bilello PA, Prichard M, Robins T, Drusano GL. Reduction of the in vitro activity of A77003, an inhibitor of human immunodeficiency virus protease, by human serum «¡-acid glycoprotein. J Infect Dis 1995;171:546-551
    • (1995) J Infect Dis , vol.171 , pp. 546-551
    • Bilello, J.A.1    Bilello, P.A.2    Prichard, M.3    Robins, T.4    Drusano, G.L.5
  • 22
    • 0028846226 scopus 로고
    • Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme
    • Kim EE, Baker CT, Dwyer MD, et al. Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme. J Am Chem Soc 1995;117:1181-1182
    • (1995) J am Chem Soc , vol.117 , pp. 1181-1182
    • Kim, E.E.1    Baker, C.T.2    Dwyer, M.D.3
  • 24
    • 0025799991 scopus 로고
    • An improved colorimetric assay for cell proliferation and viability utilizing the tetra-zolium salt XTT
    • Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetra-zolium salt XTT. J Tmmunol Methods 1991;142:257-265
    • (1991) J Tmmunol Methods , vol.142 , pp. 257-265
    • Roehm, N.W.1    Rodgers, G.H.2    Hatfield, S.M.3    Glasebrook, A.L.4
  • 25
    • 0027310686 scopus 로고
    • Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV)
    • Øie S, Jacobson MA, Abrams DI. Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV). J Acquir Immune Defic Syndr 1993;5:531-533
    • (1993) J Acquir Immune Defic Syndr , vol.5 , pp. 531-533
    • Øie, S.1    Jacobson, M.A.2    Abrams, D.I.3
  • 26
    • 84959844240 scopus 로고
    • Drug binding and apparent volume of distribution
    • Tillement JP, Lindendlaub E, eds., Germany: Schattauer
    • Houin G. Drug binding and apparent volume of distribution. In: Tillement JP, Lindendlaub E, eds. Protein binding and drug transport. Stuggart, Germany: Schattauer, 1985:213-226
    • (1985) Protein Binding and Drug Transport. Stuggart , pp. 213-226
    • Houin, G.1
  • 27
    • 0027212863 scopus 로고
    • El al. Effect of human serum on the in vitro anti-HIV activity of l-[(2-hydroxyethoxy)methyl]-6(phenylthio) thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding
    • Baba M, Yuasa S, Niwa T, el al. Effect of human serum on the in vitro anti-HIV activity of l-[(2-hydroxyethoxy)methyl]-6(phenylthio) thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding. Biochem Phdrmacol 1993;45:2507-2512
    • (1993) Biochem Phdrmacol , vol.45 , pp. 2507-2512
    • Baba, M.1    Yuasa, S.2    Niwa, T.3
  • 28
    • 0019952227 scopus 로고
    • Importance of protein binding for the interpretation of serum or plasma drug concentration
    • Greenblatt DJ, Sellers EM, Koch-Weser J. Importance of protein binding for the interpretation of serum or plasma drug concentration. J Clin Pharmacol 1982; 22:259-63
    • (1982) J Clin Pharmacol , vol.22 , pp. 259-263
    • Greenblatt, D.J.1    Sellers, E.M.2    Koch-Weser, J.3
  • 29
    • 0023690101 scopus 로고
    • Drug binding to human alpha-1 -acid glycoprotein in health and disease
    • Kremer JMH, Wilting J, Janssen LHM. Drug binding to human alpha-1 -acid glycoprotein in health and disease. Phannacol Rev 1988;40:1-47
    • (1988) Phannacol Rev , vol.40 , pp. 1-47
    • Kremer, J.1    Wilting, J.2    Janssen, L.3
  • 30
    • 0021041788 scopus 로고
    • In vivo binding of propranolol and progesterone to native and desialylated human orosomucoid
    • Wong AKL, Hsia JC. In vivo binding of propranolol and progesterone to native and desialylated human orosomucoid. Can J Biochem Cell Biol 1983;61:1114-1116
    • (1983) Can J Biochem Cell Biol , vol.61 , pp. 1114-1116
    • Wong, A.1    Hsia, J.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.